These findings are in agreement with our results showing that TGFβ, via LIF/STAT3 activation, leads to the suppression of the invasive phenotype in melanoma and highlight TGFβ as a favorable prognosis marker and protective growth factor against tumor metastasis in human melanoma. This evidence concerns the gene TGFB1 and neoplasm.